Santa Cruz Biotechnology

PADI4 (A-11) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; PADI4 Antibody (A-11) is an IgG2a κ mouse monoclonal PADI4 antibody (also designated PADI4 antibody) that detects the PADI4 protein of human origin by WB, IP, IF and ELISA. PADI4 Antibody (A-11) is available as both the non-conjugated anti-PADI4 antibody form, as well as multiple conjugated forms of anti-PADI4 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The protein arginine deiminase (PAD) family of proteins are often referred to as peptidylarginine deiminases. They catalyze the deimination of arginine residues of proteins. In the presence of calcium, the proteins in the PAD family act as catalysts for the posttranslational modification reaction that converts methylarginine to citrulline. The PAD proteins are cytoplasmic proteins primarily detected in eosinophils and neutrophils. The gene encoding for PADI4 is believed to be a rheumatoid arthritis susceptibility locus. By increasing the citrullination of proteins in rheumatoid arthritis synovial tissues, it may play a role in the pathogenesis of the disease.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.